Deep and Prolonged Response to Aurora A Kinase Inhibitor and Subsequently to Nivolumab in MYCL1-Driven Small-Cell Lung Cancer: Case Report and Literature Review

Small-cell lung carcinoma (SCLC) is one of the most aggressive solid tumors, and the prognosis has not improved significantly in 25 years. Despite a recent understanding of the genomic aberrations seen in SCLC, these insights have not led to any breakthroughs in treatment. We present a patient with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolla, Bhaskar C., Racila, Emilian, Patel, Manish R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166265/
https://www.ncbi.nlm.nih.gov/pubmed/32318301
http://dx.doi.org/10.1155/2020/8026849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166265/
https://www.ncbi.nlm.nih.gov/pubmed/32318301
http://dx.doi.org/10.1155/2020/8026849

Ejemplares similares